Mutations in donors' stem cells may cause problems for cancer patients

byWashington University School of MedicineA new study from Washington University School of Medicine in St. Louis suggests that bone marrow -- or blood stem cells -- from healthy donors can harbo

Updated on: December 22,2023

Mutations in donors' stem cells may cause problems for cancer patients

byWashington University School of MedicineA new study from Washington University School of Medicine in St. Louis suggests that bone marrow -- or blood stem cells -- from healthy donors can harbo

Updated on:December 22,2023

Lung cancer screening increases percentage of Stage I cases detected, while reducing percentage of Stage IV cases

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainImplementing lung cancer screening at four diverse healthcare systems resulted in an 8.4 percent increase in t

Updated on: December 22,2023

Lung cancer screening increases percentage of Stage I cases detected, while reducing percentage of Stage IV cases

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainImplementing lung cancer screening at four diverse healthcare systems resulted in an 8.4 percent increase in t

Updated on:December 22,2023

The obesity paradox in lung cancer diagnosis may differ by race

by Makhari Dysart,Thomas Jefferson UniversityCredit: Pixabay/CC0 Public DomainLung cancer is the leading cause of cancer death in the U.S., making up 25% of cancer deaths. With obesity rates sim

Updated on: December 22,2023

The obesity paradox in lung cancer diagnosis may differ by race

by Makhari Dysart,Thomas Jefferson UniversityCredit: Pixabay/CC0 Public DomainLung cancer is the leading cause of cancer death in the U.S., making up 25% of cancer deaths. With obesity rates sim

Updated on:December 22,2023

Survival 21 percent a year after ICU discharge for blood cancer patients

by Elana GotkineFor hematologic malignancy (HM) patients admitted to the intensive care unit (ICU), survival is 49 percent at seven days and 21 percent at 12 months, according to a study published onl

Updated on: March 30,2024

Survival 21 percent a year after ICU discharge for blood cancer patients

by Elana GotkineFor hematologic malignancy (HM) patients admitted to the intensive care unit (ICU), survival is 49 percent at seven days and 21 percent at 12 months, according to a study published onl

Updated on:March 30,2024

Mediterranean diet improves immunotherapy response rates and progression-free survival in advanced melanoma

by United European GastroenterologyCredit: Unsplash/CC0 Public DomainEating a Mediterranean diet rich in fiber, mono-unsaturated fatty acids and polyphenols, has been associated with improved immunoth

Updated on: December 20,2023

Mediterranean diet improves immunotherapy response rates and progression-free survival in advanced melanoma

by United European GastroenterologyCredit: Unsplash/CC0 Public DomainEating a Mediterranean diet rich in fiber, mono-unsaturated fatty acids and polyphenols, has been associated with improved immunoth

Updated on:December 20,2023

American cancer survivors face substantial financial hardship and financial sacrifices

byAmerican Association for Cancer ResearchAmerican cancer survivors, particularly those 64 years or younger, faced substantial medical financial hardship and sacrifices in spending, savings, or

Updated on: December 20,2023

American cancer survivors face substantial financial hardship and financial sacrifices

byAmerican Association for Cancer ResearchAmerican cancer survivors, particularly those 64 years or younger, faced substantial medical financial hardship and sacrifices in spending, savings, or

Updated on:December 20,2023

Patients with cancer, suppressed immune system at high risk for severe COVID if treated with systemic drug therapies

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPatients with cancer and a weakened immune system who are treated with immunotherapies tend to fare far worse from COVID-19 than t

Updated on: December 18,2023

Patients with cancer, suppressed immune system at high risk for severe COVID if treated with systemic drug therapies

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPatients with cancer and a weakened immune system who are treated with immunotherapies tend to fare far worse from COVID-19 than t

Updated on:December 18,2023

New pancreatic cancer research could boost survival rates

byCU Anschutz Medical CampusGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.04.001A unique treatment combining radiation and immunotherapy can eradicate pancr

Updated on: January 13,2024

New pancreatic cancer research could boost survival rates

byCU Anschutz Medical CampusGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.04.001A unique treatment combining radiation and immunotherapy can eradicate pancr

Updated on:January 13,2024

Study shows which patients with advanced prostate cancer will benefit from chemotherapy

by University College LondonProstate cancer cells. Credit: NIH Image GalleryResearchers have recommended changes to how cancer patients are treated, after a new UCL-led study discovered that chem

Updated on: April 03,2024

Study shows which patients with advanced prostate cancer will benefit from chemotherapy

by University College LondonProstate cancer cells. Credit: NIH Image GalleryResearchers have recommended changes to how cancer patients are treated, after a new UCL-led study discovered that chem

Updated on:April 03,2024

Comparison of FDG-PET/CT and CT for treatment evaluation of patients with unresectable malignant pleural mesothelioma

by Impact Journals LLCEpithelioid MPM, stage IIIB (cT4N0M0), woman, 64 years old. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28594A new research paper titled "Comparison of FDG

Updated on: July 17,2024

Comparison of FDG-PET/CT and CT for treatment evaluation of patients with unresectable malignant pleural mesothelioma

by Impact Journals LLCEpithelioid MPM, stage IIIB (cT4N0M0), woman, 64 years old. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28594A new research paper titled "Comparison of FDG

Updated on:July 17,2024

Colon cancer is being spotted in younger people, and at later stages

by Steven ReinbergColon cancer continues to rise among younger U.S. adults, with the American Cancer Society reporting a doubling of cases in people younger than 55 in about 25 years.Also, significant

Updated on: December 26,2023

Colon cancer is being spotted in younger people, and at later stages

by Steven ReinbergColon cancer continues to rise among younger U.S. adults, with the American Cancer Society reporting a doubling of cases in people younger than 55 in about 25 years.Also, significant

Updated on:December 26,2023

Major response to immunotherapy in early-stage mismatch repair deficient colon cancer

byEuropean Society for Medical OncologyCredit:Annals of OncologyPre-operative treatment with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab achieves major patho

Updated on: December 18,2023

Major response to immunotherapy in early-stage mismatch repair deficient colon cancer

byEuropean Society for Medical OncologyCredit:Annals of OncologyPre-operative treatment with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab achieves major patho

Updated on:December 18,2023